Rachel provides strategic guidance to clients on health policy issues and federal legislation in a continuously evolving healthcare space. She draws on her background that includes both patient and provider advocacy as well as private equity research, to provide solutions for a diverse array of healthcare clients.
Rachel combines experience researching and analyzing policy issues, including provider reimbursement, antitrust, telehealth, health equity, value-based care, health data and the pharmaceutical space to deliver insights and develop strategies to support clients’ business objectives.
Before joining McDermottPlus, Rachel served as a senior analyst with a national health organization that supports health systems navigating unique industry challenges. In that role, she partnered with C-suite executives, senior government officials and health policy experts to generate policy solutions and drive high-impact healthcare reform. Previously, Rachel worked for a boutique firm where she regularly interfaced with private equity and health care investors to identify potential market risks and opportunities.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.